Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Freeman · SciRah

Researcher profile · Semantic Scholar

M. Freeman

Share profile

M. Freeman — researcher profile on SciRah

h-index: 10
Works: 46
Citations: 741

Most-cited papers

Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
D. Coit, John A. Thompson, M. Albertini, C. Barker +26 more
2019The Journal of the National Comprehensive Cancer Network359 citations
Semantic Scholar
Ultrasonography in Preclinical Education: A Pilot Study
Virginia A Syperda, P. N. Trivedi, Lauren C Melo, M. Freeman +3 more
2008The Journal of the American Osteopathic Association85 citations
Semantic Scholar
Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinoma.
S. Keeping, Yingxin Xu, Chieh-I Chen, S. Cope +15 more
2020Future Oncology47 citations Open access
Semantic Scholar
Surveillance imaging for metastasis in high-risk melanoma: importance in individualized patient care and survivorship
M. Freeman, S. Laks
2019Melanoma Management37 citations Open access
Semantic Scholar
CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma.
M. Migden, S. Chandra, G. Rabinowits, Chieh-I Chen +10 more
2020Future Oncology31 citations Open access
Semantic Scholar
Induction of the Abscopal Effect with Immunotherapy and Palliative Radiation in Metastatic Head and Neck Squamous Cell Carcinoma: A Case Report and Review of the Literature
A. Shinde, J. Novak, M. Freeman, S. Glaser +1 more
2019Cureus24 citations Open access
Semantic Scholar
Subset analysis of the safety and efficacy of nivolumab in elderly patients with metastatic melanoma
M. Freeman, J. Weber
2015Journal of Immunotherapy for Cancer24 citations Open access
Semantic Scholar
Cancer Immunotherapy Principles and Practice
L. Butterfield, H. Kaufman, F. Marincola, T. Gajewski +127 more
201820 citations
Semantic Scholar
Cutaneous Melanoma , Version 2 . 2019
D. Coit, John A. Thompson, M. Albertini, C. Barker +26 more
201916 citations
Semantic Scholar
Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma
G. Rabinowits, M. Migden, T. Schlesinger, R. Ferris +7 more
2021JID Innovations14 citations Open access
Semantic Scholar
Pathologic complete response with radiation and vismodegib in a patient with advanced basal cell carcinoma: A case report
A. Amini, M. Freeman, L. Melstrom, K. Margolin +3 more
2021Molecular and clinical oncology10 citations Open access
Semantic Scholar
Identifying Valuable Resources
M. Freeman, Do, Facp.
201910 citations
Semantic Scholar
Indirect Treatment Comparison of Nivolumab Versus Observation or Ipilimumab as Adjuvant Therapy in Resected Melanoma Using Pooled Clinical Trial Data
M. Freeman, K. Betts, Sha-sha Jiang, E. Du +4 more
2019Advances in Therapy10 citations Open access
Semantic Scholar
Clinical Response to Pazopanib in a Patient With KDR-Mutated Metastatic Basal Cell Carcinoma.
T. Knepper, M. Freeman, G. Gibney, H. McLeod +1 more
2017JAMA dermatology10 citations
Semantic Scholar
Treatment patterns of malignant melanoma in the United States from 2011 to 2016: a retrospective cohort study
Shweta Shah, L. Raskin, D. Cohan, M. Freeman +1 more
2020Current Medical Research and Opinion8 citations
Semantic Scholar
The Effect of Time to Postoperative Radiation Therapy on Survival in Resected Merkel Cell Carcinoma
A. Shinde, V. Verma, B. Jones, Richard Li +7 more
2019American Journal of Clinical Oncology8 citations
Semantic Scholar
The association between facility volume and overall survival in patients with Merkel cell carcinoma
E. Yoshida, M. Luu, M. Freeman, R. Essner +6 more
2020Journal of Surgical Oncology7 citations
Semantic Scholar
Effect of a multidisciplinary-assisted resident diabetes clinic on resident knowledge and patient outcomes.
Margaret C. Lo, M. Freeman, M. Lansang
2013Journal of Graduate Medical Education5 citations Open access
Semantic Scholar
Indirect treatment comparison of nivolumab versus placebo as an adjuvant therapy for resected melanoma.
A. Shoushtari, M. Freeman, K. Betts, K. Gupte-Singh +3 more
20184 citations
Semantic Scholar
Factors predictive of 90‐day mortality after surgical resection for oral cavity cancer: Development of a recursive partitioning analysis for risk stratification
A. Shinde, B. Jones, M. Luu, Richard Li +9 more
2021Head and Neck3 citations
Semantic Scholar
Treatment patterns of melanoma by BRAF mutation status in the USA from 2011 to 2017: a retrospective cohort study
Shweta Shah, L. Raskin, D. Cohan, O. Hamid +1 more
2019Melanoma Management3 citations Open access
Semantic Scholar
Assessing the value of nivolumab (NIVO) versus placebo (PBO) and ipilimumab (IPI) as adjuvant therapy for resected melanoma.
M. Freeman, A. Shoushtari, K. Betts, K. Gupte-Singh +3 more
20183 citations
Semantic Scholar
State of Cancer Care in America: Reflections on an Inaugural Year.
B. Polite, Jerome E. Seid, M. Freeman, Laura A. Levit +4 more
2019Journal of Oncology Practice2 citations
Semantic Scholar
Preliminary interim results of the first-in-human, dose-finding PROCLAIM-CX-072 trial of the PD-L1 Probody therapeutic (Pb-Tx) CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors.
R. Sanborn, C. W. Menke, K. Autio, H. Arkenau +13 more
20182 citations
Semantic Scholar
Multidisciplinary Expert-Driven Consensus on the Evolving Treatment of Patients with Advanced Cutaneous Squamous Cell Carcinoma
M. Migden, T. Schlesinger, C. Schmults, S. Dinehart +8 more
2019SKIN The Journal of Cutaneous Medicine0 citations Open access
Semantic Scholar
Navigators: Crucial Members of the Team
M. Freeman, Do, Facp.
20190 citations
Semantic Scholar
Is Immunotherapy Appropriate Here
M. Freeman, Do, Facp.
20190 citations
Semantic Scholar
Patients: Don't Go It Alone
M. Freeman, Do, Facp.
20190 citations
Semantic Scholar
Navigator's Role in Adverse Event Management
M. Freeman, Do, Facp.
20190 citations
Semantic Scholar
Educating the Patient
M. Freeman, Do, Facp.
20190 citations
Semantic Scholar
Dealing with Misinformation
M. Freeman, Do, Facp.
20190 citations
Semantic Scholar
Immunotherapy vs Targeted Therapy
M. Freeman, Do, Facp.
20190 citations
Semantic Scholar
The Evolving Field of Treatment Modalities
M. Freeman, Do, Facp.
20190 citations
Semantic Scholar
Changing the Conversation: Immunotherapy and Long-Term Survival
M. Freeman, Do, Facp.
20190 citations
Semantic Scholar
Assessment of real-world effectiveness of first-line (1L) nivolumab (NIVO) plus ipilimumab (IPI) or NIVO monotherapy for advanced melanoma: A retrospective cohort study.
M. Freeman, Komal Gupte-Singh, M. You, T. Le +3 more
2018Annals of Oncology0 citations Open access
Semantic Scholar
What Happens After Immunotherapy
M. Freeman, Do, Facp.
20180 citations
Semantic Scholar
Metrics Help Promote High-Quality Care
M. Freeman, Do, Facp.
20170 citations
Semantic Scholar
Advances in clinical immunotherapy of melanoma
Kathryn Bollin, M. Freeman
20170 citations
Semantic Scholar
Navigators Are a Bridge for Patients
M. Freeman, Do, Facp.
20170 citations
Semantic Scholar
Practices: Send Your Navigators to AONN+ Meetings
M. Freeman, Do, Facp.
20170 citations
Semantic Scholar
Clinicians: Come to an AONN+ Conference
M. Freeman, Do, Facp.
20170 citations
Semantic Scholar
What Your Patient Needs to Know About Immunotherapy
M. Freeman, Do, Facp.
20170 citations
Semantic Scholar
As a Physician, I Rely on Navigators
M. Freeman, Do, Facp.
20170 citations
Semantic Scholar
Tanning Bed Legislation in 2016: are we any Closer to Closing the Lid?
M. Freeman
20160 citations Open access
Semantic Scholar
Nursing Management of Advanced Merkel Cell Carcinoma.
Pam Lowry, M. Freeman, J. Russell
2016Oncology Nursing Forum0 citations
Semantic Scholar
Abstract 1409: Is it what's on the inside that counts? Melanoma mutation profiling and outcomes with immunotherapy
M. Freeman, H. McLeod
20160 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Do×17
Invite
Do — researcher profile on SciRah
Facp.×17
Invite
Facp. — researcher profile on SciRah
V. Guild×4
Invite
V. Guild — researcher profile on SciRah
A. Amini×4
Invite
A. Amini — researcher profile on SciRah

×4

Invite

O. Hamid — researcher profile on SciRah

Invite

W. Carson — researcher profile on SciRah

Invite

P. Ott — researcher profile on SciRah

Invite

M. Migden — researcher profile on SciRah

G. Rabinowits×3

Invite

G. Rabinowits — researcher profile on SciRah

Invite

A. Shinde — researcher profile on SciRah

Invite

S. Glaser — researcher profile on SciRah

Invite

R. Ferris — researcher profile on SciRah